Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

9.559 +0.729 (+8.26%)
Streaming Delayed Price Updated: 3:39 PM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
The biotech industry offers investors unique investment opportunities but these three are biotechs to sell. 
Via InvestorPlace
Exit Alert: 3 Overhyped Stocks With Weak Fundamentals
These are overhyped stocks to sell as they represent companies with weak fundamentals and prospects of cash burn. 
Via InvestorPlace
Is Novavax a Buy Now?
The stock has dropped 98% over the past three years. 
Via The Motley Fool
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Can the stock's recent rally continue? 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Novavax's Earnings Outlook
Via Benzinga
Has Novavax Just Solved Its Biggest Problem?
The biotech company recently settled a dispute with a major customer. 
Via The Motley Fool
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
Why Is Advance Auto Parts (AAP) Stock Trending Today?
Advance Auto Parts stock is up on Wednesday even after posting EPS and revenue misses in its earnings report for the fourth quarter of 2023. 
Via InvestorPlace
Better Bull Market Buy: Novavax vs. Pfizer
Bull markets usually favor stocks with promising growth prospects. 
Via The Motley Fool
Where Will Novavax Be in 10 Years?
Without any windfalls on the horizon, times are dire for this biotech. 
Via The Motley Fool
Better Recovery Story Buy: Novavax vs. Teladoc
Both stocks have fallen more than 90% from their peak. 
Via The Motley Fool
Why Is COVID-19 Vaccine Maker Novavax Stock Plunging On Wednesday?
Novavax reports Q4 2023 revenue of $291 million, missing consensus. Restructuring brings 30% workforce reduction. Anticipates COVID-19-Influenza combo vaccine Phase 3 in H2 2024. FY 2024 revenue... 
Via Benzinga
Exposures COVID-19
NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today
Novavax stock is falling hard on Wednesday as NVAX investors react to it missing estimates for Q4 and posting weak guidance for 2024! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today
The U.S. indices were mixed with the S&P 500 rising by nearly 0.2% to 5,078.18 and the Dow Jones Industrial Average falling by 0.25% to 38,972.41. 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Could Novavax Stock Help You Become a Millionaire?
Novavax aims to win with its coronavirus/flu vaccine candidate, now in clinical trials. 
Via The Motley Fool
Earnings Scheduled For February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
Via Benzinga
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc. 
Via Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Morgan Stanley Is Pounding the Table on DoorDash (DASH) Stock
DoorDash stock is rising higher on Thursday after Morgan Stanley upgraded DASH shares and increased their price target for them. 
Via InvestorPlace
Morgan Stanley Issues a Warning on Rivian (RIVN) Stock
Rivian stock is falling hard on Friday as RIVN investors react to a warning from Morgan Stanley and a weak EV production guidance for 2024. 
Via InvestorPlace
What's Going On With Novavax Stock Today?
Novavax said it reached a settlement with Gavi related to the 2021 advance purchase agreement for Novavax's prototype COVID-19 vaccine. The agreement brings the pending arbitration related to the... 
Via Benzinga
Exposures COVID-19
NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute
Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi. 
Via InvestorPlace
Exposures COVID-19
Get Rich Quick With These 3 Stocks to Buy Now
Although these market ideas are extremely speculative, their upcoming catalysts could make them stocks to buy now. 
Via InvestorPlace
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly. 
Via InvestorPlace
3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market
Bull markets favor growth stocks so now could be the time for these players to shine. 
Via The Motley Fool
Novavax's Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable Option
Novavax's R21/Matrix-M malaria vaccine, with 75% efficacy in seasonal areas. Affordable at $3 per dose, it outshines GSK's vaccine. Global rollout expected mid-2024. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.